Comparative Efficacy of China’s Domestic versus Imported PD-1/PD-L1 Inhibitor-Based Combinations as First-Line Therapy for Advanced Non-small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis

SSRN Electronic Journal 2026 Preprint Open access

Read full text
Authors: Jingting Yang, Rui Min, Hongcheng Zhong, Yuanjia Hu, See PDF
DOI: 10.2139/ssrn.6021360
Cited by: 0

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations Lung Cancer Diagnosis and Treatment

Publication details

Journal / source
SSRN Electronic Journal
Publication date
1 January 2026
Document type
Preprint